Janney Montgomery Scott
RANI icon

Janney Montgomery Scott’s Rani Therapeutics RANI Stock Holding History

Janney Montgomery Scott’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36K Hold
49,200
– – ﹤0.01% 2728
2025
Q4 		$66K Hold
49,200
– – ﹤0.01% 2885
2025
Q3 		$25K Sell
49,200
-6,000
-11% -$3.13K ﹤0.01% 2842
2025
Q2 		$28K Buy
55,200
+28,000
+103% +$22.8K ﹤0.01% 2683
2025
Q1 		$34K Hold
27,200
– – ﹤0.01% 2645
2024
Q4 		$37K Buy
+27,200
New +$57.2K ﹤0.01% 2665

Other funds holding RANI

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCP
SymBiosis Capital Partners Bentonville, Arkansas $52.8M AUM
LP
Longaeva Partners Chicago, Illinois $2.7B AUM 37.16% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

Janney Montgomery Scott's RANI Position: Q1 2026 in Review

Janney Montgomery Scott held its Rani Therapeutics (RANI) position steady in Q1 2026 at 49,200 shares worth $36K. The position accounts for ﹤0.01% of the portfolio, ranked #2728.

Janney Montgomery Scott first reported a position in RANI in Q4 2024 and has held it in 6 quarters since. The position peaked at $66K in Q4 2025. 74 funds tracked by Wall St. Rank hold RANI as of Q1 2026.

  • Janney Montgomery Scott held 49,200 shares of Rani Therapeutics worth $36K as of Q1 2026.
  • Janney Montgomery Scott left its Rani Therapeutics share count unchanged in Q1 2026.
  • Rani Therapeutics made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q1 2026, its #2728 holding.
  • Janney Montgomery Scott first reported a position in Rani Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • Janney Montgomery Scott's Rani Therapeutics position peaked at $66K in Q4 2025.
  • 74 funds tracked by Wall St. Rank held Rani Therapeutics as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.